Skip to Main Content

Pandemics, Epidemics, and Vaccines: History, Science, & Controversies: Human Papilloma Virus (HPV)

A research topic guide covering pandemics and epidemics as well as the history, science, and controversies of vaccines.

Resources

Research & Reference

Streaming Media

Perspectives

The HPV Vaccine Controversy

The Human Papilloma Virus, so-called HPV, is one of the most widespread sexually transmitted diseases in America, with more than 20 million infected now and more than 6 million new cases detected each year. It is estimated that at least 50 percent of all sexually active people will be infected during their lifetimes. And while the silent disease may cause no symptoms in most cases, two strains of HPV cause some 70 percent of all cervical cancer, which strikes more than 10,000 women in the United States alone each year. So it is with great fanfare than an HPV vaccine, tested around the world and approved by the US government in 2006, is being marketed. But controversy surrounds the vaccine, which is being recommended for girls as young as 9 and may be mandated by state governments. In this timely book, Shobha Krishnan, M.D., of Barnard College, Columbia University - a longtime gynecologist and family physician, and mother of a young daughter - explains in layterms both the disease and vaccine to parents, youths, men and women. She also addresses the controversy, legislative aims to require the vaccine, and another vaccine to hit the market this year. Krishnan also raises the issue of whether boys should get the vaccine. Coverage across the book is comprehensive and addresses both the pros and cons of anyone being innoculated. Parents, teenagers, and young adults considering the HPV vaccine will find all of the answers to their questions in this book, which also features a chapter listing all of the questions asked, and answers given, when Krishnan ran an informational clinic for college students curious about the disease and the vaccine. The book also addresses the need for vaccine booster shots, what is known about side effects, and whether or not it can protect boys from contracting or transmitting the virus, or getting genital warts. In addition, a final chapter highlights some of the personal stories and anecdotes of cervical cancer from women in developing countries, and the role the vaccines could play in those countries.

Three Shots at Prevention

In 2007, Texas governor Rick Perry issued an executive order requiring that all females entering sixth grade be vaccinated against the human papillomavirus (HPV), igniting national debate that echoed arguments heard across the globe over public policy, sexual health, and the politics of vaccination. Three Shots at Prevention explores the contentious disputes surrounding the controversial vaccine intended to protect against HPV, the most common sexually transmitted infection. When the HPV vaccine first came to the market in 2006, religious conservatives decried the government's approval of the vaccine as implicitly sanctioning teen sex and encouraging promiscuity while advocates applauded its potential to prevent 4,000 cervical cancer deaths in the United States each year. Families worried that laws requiring vaccination reached too far into their private lives. Public health officials wrestled with concerns over whether the drug was too new to be required and whether opposition to it could endanger support for other, widely accepted vaccinations. Many people questioned the aggressive marketing campaigns of the vaccine's creator, Merck & Co. And, since HPV causes cancers of the cervix, vulva, vagina, penis, and anus, why was the vaccine recommended only for females? What did this reveal about gender and sexual politics in the United States? With hundreds of thousands of HPV-related cancer deaths worldwide, how did similar national debates in Europe and the developing world shape the global possibilities of cancer prevention? This volume provides insight into the deep moral, ethical, and scientific questions that must be addressed when sexual and social politics confront public health initiatives in the United States and around the world.